Daniel Bensen, Chief Operating Officer at Tyra Biosciences, Inc. (TYRA), sold 3,702 shares at $20.00 ($74K) on 2024-06-10, disclosed to the SEC on 2024-06-10.
Scheduled sale ($74k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.00 | 200 | $4K | 5.4% |
| 2 | $20.00 | 3,502 | $70K | 94.6% |
| Total | $20.00 avg | 3,702 | $74K | 100% |
| Filing → |
| TYRA | SELL | 2025-12-16 | $181K | — | Filing → |
| TYRA | SELL | 2025-11-19 | $4.1M | — | Filing → |
| TYRA | SELL | 2025-11-17 | $4.2M | — | Filing → |